Claritev (NYSE:CTEV) reported quarterly earnings results on February 23, 2026 that fell short of analyst expectations.
The Healthcare company reported earnings per share of $-4.88, missing the consensus estimate of $-1.07 by $3.81 per share. Revenue came in at $246.6M, beating the estimate of $241.3M.
Claritev's stock moved following the earnings release. The stock currently trades at $18.74 with a market capitalization of $641.2M.